Comparison of Bisulfite Pyrosequencing and Methylation-Specific qPCR for Methylation Assessment
暂无分享,去创建一个
A. Fernández-Villar | D. Valverde | M. Rodríguez-Girondo | L. De Chiara | V. Leiro-Fernández | M. Botana-Rial
[1] C. Šálek,et al. DNA Methylation Validation Methods: a Coherent Review with Practical Comparison , 2019, Biological Procedures Online.
[2] B. Singer,et al. A Practical Guide to the Measurement and Analysis of DNA Methylation. , 2019, American journal of respiratory cell and molecular biology.
[3] A. Fernández-Villar,et al. Methylation Assessment for the Prediction of Malignancy in Mediastinal Adenopathies Obtained by Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration in Patients with Lung Cancer , 2019, Cancers.
[4] Y. Assenov,et al. Intratumor heterogeneity in epigenetic patterns. , 2018, Seminars in cancer biology.
[5] Zhang Huayu,et al. P16 INK4a gene promoter methylation as a biomarker for the diagnosis of non‐small cell lung cancer: An updated meta‐analysis , 2018, Thoracic cancer.
[6] L. Stuyver,et al. Droplet digital PCR is an accurate method to assess methylation status on FFPE samples , 2018, Epigenetics.
[7] Guohong Liu,et al. DNA methylation profiles in cancer diagnosis and therapeutics , 2018, Clinical and Experimental Medicine.
[8] M. Esteller,et al. Lung cancer epigenetics: From knowledge to applications. , 2017, Seminars in cancer biology.
[9] J. Herman,et al. Early Detection of Lung Cancer Using DNA Promoter Hypermethylation in Plasma and Sputum , 2016, Clinical Cancer Research.
[10] K. Liestøl,et al. Experimental factors affecting the robustness of DNA methylation analysis , 2016, Scientific Reports.
[11] Kimberly Walter,et al. Quantitative comparison of DNA methylation assays for biomarker development and clinical applications , 2016, Nature Biotechnology.
[12] M. Bullock,et al. DNA Methylation Analysis: Choosing the Right Method , 2016, Biology.
[13] V. Kristensen,et al. Heterogeneous DNA Methylation Patterns in the GSTP1 Promoter Lead to Discordant Results between Assay Technologies and Impede Its Implementation as Epigenetic Biomarkers in Breast Cancer , 2015, Genes.
[14] G. Barreto,et al. Epigenetics in lung cancer diagnosis and therapy , 2015, Cancer and Metastasis Reviews.
[15] Martin S. Taylor,et al. Quantification of epigenetic biomarkers: an evaluation of established and emerging methods for DNA methylation analysis , 2014, BMC Genomics.
[16] T. Liloglou,et al. Epigenetic biomarkers in lung cancer. , 2014, Cancer letters.
[17] L. Tanoue,et al. Methods for staging non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. , 2013, Chest.
[18] F. Coppedè,et al. Comparison Study of MS-HRM and Pyrosequencing Techniques for Quantification of APC and CDKN2A Gene Methylation , 2013, PloS one.
[19] M. Sanson,et al. Comparative assessment of 5 methods (methylation‐specific polymerase chain reaction, methylight, pyrosequencing, methylation‐sensitive high‐resolution melting, and immunohistochemistry) to analyze O6‐methylguanine‐DNA‐methyltranferase in a series of 100 glioblastoma patients , 2012, Cancer.
[20] C. Plass,et al. A systematic comparison of quantitative high-resolution DNA methylation analysis and methylation-specific PCR , 2012, Epigenetics.
[21] Nicola Torelli,et al. Clustering via nonparametric density estimation , 2007, Stat. Comput..
[22] D. Mccrory,et al. Endoscopic ultrasound-guided fine-needle aspiration for non-small cell lung cancer staging: A systematic review and metaanalysis. , 2007, Chest.
[23] N. Cross,et al. Quantitative Analysis of SRNPN Gene Methylation by Pyrosequencing as a Diagnostic Test for Prader–Willi Syndrome and Angelman Syndrome , 2006 .
[24] Shuji Ogino,et al. Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis. , 2006, The Journal of molecular diagnostics : JMD.
[25] S. Goodman,et al. Gene promoter hypermethylation in tumors and lymph nodes of stage I lung cancer patients. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[26] J. Herman,et al. Molecular progression of promoter methylation in intraductal papillary mucinous neoplasms (IPMN) of the pancreas. , 2003, Carcinogenesis.
[27] P. Laird,et al. MethyLight: a high-throughput assay to measure DNA methylation. , 2000, Nucleic acids research.
[28] D. Sidransky,et al. Role of the p16 tumor suppressor gene in cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] J. Herman,et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[30] J. Herman,et al. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers , 1995, Nature Medicine.
[31] Qihong Huang,et al. Clinical Significance of P16 Gene Methylation in Lung Cancer. , 2020, Advances in Experimental Medicine and Biology.
[32] I. Gut,et al. Analysis of gene-specific DNA methylation patterns by pyrosequencing technology. , 2007, Methods in molecular biology.
[33] N. Cross,et al. Quantitative analysis of SNRPN(correction of SRNPN) gene methylation by pyrosequencing as a diagnostic test for Prader-Willi syndrome and Angelman syndrome. , 2006, Clinical chemistry.